Literature DB >> 27618771

Kidney cancer: Sunitinib resistance is futile.

Louise Stone.   

Abstract

Entities:  

Year:  2016        PMID： 27618771     DOI： 10.1038/nrurol.2016.180

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  MEK inhibition abrogates sunitinib resistance in a renal cell carcinoma patient-derived xenograft model.

Authors:  C Marcela Diaz-Montero; Frances J Mao; John Barnard; Yvonne Parker; Maryam Zamanian-Daryoush; John J Pink; James H Finke; Brian I Rini; Daniel J Lindner
Journal:  Br J Cancer       Date:  2016-08-25       Impact factor: 7.640
  1 in total
  1 in total

1.  Sphingosine kinase 1 overexpression contributes to sunitinib resistance in clear cell renal cell carcinoma.

Authors:  Yunze Xu; Baijun Dong; Jianfeng Wang; Jin Zhang; Wei Xue; Yiran Huang
Journal:  Oncoimmunology       Date:  2018-09-25       Impact factor: 8.110
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.